Kimba

Company Overview

Snapshot

Founded in January 2024 by Ben Fuxbruner and Gabi Beck, Kimba operates with 1–10 employees. The company has raised $6.5M across two funding rounds from seven investors.

Business overview

Kimba develops scent-based personal limbic therapy, leveraging AI to analyze biometric data and provide personalized scent therapy. This technology aims to improve sleep and overall health, serving markets within the health tech and life sciences sectors, specifically addressing sleep disorders, mental health, wellness, and well-being.

Strategic signal

In June 2026, Kimba emerged from stealth mode, revealing its AI-powered, scent-based therapy system designed to enhance sleep quality and recovery. This signals a significant product launch and market entry for the company, positioning it as an innovator in personalized health solutions, particularly for individuals with sleep issues, including those with PTSD.

Company Intelligence Q&A

What is Kimba's core technology?

Kimba utilizes AI and scent technology to provide personalized limbic therapy, analyzing biometric data to offer tailored scent experiences aimed at improving sleep and health.

When was Kimba founded and by whom?

Kimba was founded in January 2024 by co-founders Ben Fuxbruner, who serves as CEO, and Gabi Beck, the CTO.

What is Kimba's primary focus in the market?

Kimba focuses on improving sleep quality and recovery through its AI and personalized scent therapy system, particularly targeting individuals with sleep disorders and those seeking mental health and wellness solutions.